T cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumor burden in multiple murine syngeneic models of solid cancer

Geoffrey Parriott
Longwood University
January 1, 2020
Immunology
https://pubmed.ncbi.nlm.nih.gov/32144940

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/32144940

Research summary

This study developed a chimeric PD1 (chPD1) receptor by fusing the extracellular domain of PD1 with the intracellular signaling domains of Dap10 and CD3ζ. T cells expressing this chPD1 receptor were tested across various syngeneic murine models of solid tumors, including melanoma, pancreatic, renal, colon, liver, prostate, bladder, and breast cancers. The chPD1 T cells effectively lysed PD-L1/PD-L2-expressing tumor cells, secreted pro-inflammatory cytokines (e.g., IFN-γ, TNF-α, IL-2, GM-CSF, IL-17, IL-21), and led to long-term tumor-free survival. Additionally, treatment induced protective host anti-tumor memory responses without significant off-target effects on healthy tissues.

Key outcome of the study

ChPD1 T cells demonstrated potent anti-tumor activity across multiple solid tumor models, induced durable immune memory, and exhibited minimal toxicity to normal tissues, highlighting their potential as a universal CAR T-cell therapy for solid tumors.

Mouse model

Syngeneic immunocompetent mouse models (e.g., C57BL/6, BALB/c) bearing PD-L1/PD-L2-expressing tumors; T cells were genetically modified to express the chPD1 receptor.

TARGET:
PDCD1, HCST, CD247
PD1, DAP10, CD3ζ

Keywords

Cancer immunotherapy, Chimeric antigen receptor (CAR) T cells, PD1 ligands, Solid tumors, T cell activation

Technical specifications

Syngeneic mouse models, Chimeric receptor engineering, T cell transduction, Immunocompetent tumor models

Related products

Catalogue product

genO-MC38-hPD-L1-LZ

The genO-MC38-hPD-L1-LZ clonal cell line expresses high levels of  human PD-L1 and forms solid tumors in vivo. An optimized version of a  luciferase-ZsGreen (LZ) fusion protein is also stably expressed for in vivo imaging and ex vivo tracking.

Customized product

No items found.